Skip to main content

Advertisement

Table 3 Trial outcomes in Routine F/U patients

From: Attrition in longitudinal randomized controlled trials: home visits make a difference

CARDIAC AND NEUROLOGIC MORBIDITY AND MORTALITY (N=192) P # OF COMPLICATIONS
Low MAP (n=101) 15.8%   Perioperative 13
   6 months 4
   Total 17
  0.022  
High MAP (n=91) 5.5%   Perioperative 4
   6 months 3
    Total 5
Total Cardiac and neurologic morbidity and mortality 10.9%   Total 21
Neurocognitive Dysfunction Cardiac and Neurologic Morbidity and Mortality at 6 months (n=166)
Low MAP 11.6% 0.68 6 months 10
High MAP 13.8%   6 months 11
Total 12.7%    21
Functional Decline at 6 months n=160)
Low MAP 9.4% 0.38 6 months 8
High MAP 5.3%   6 months 4
Total 7.5%    12
Combined Trial Outcome (n=192)
Low MAP 31.7% 0.061   32
High MAP 19.8%    18
Total 26.0%    50
  1. (Surveillance on 248 participants perioperatively and 187 participants at 6 months).